Short-course hormonal therapy and the risk of death from prostate cancer in men with intermediate-risk prostate cancer undergoing high-dose radiation therapy

被引:0
作者
Keane, Florence K.
Chen, Ming-Hui
Zhang, Danjie
Moran, Brian Joseph
Braccioforte, Michelle H.
D'Amico, Anthony Victor
机构
[1] Brigham & Womens Hosp, Harvard Radiat Oncol Program, Boston, MA 02115 USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1200/jco.2015.33.7_suppl.27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
27
引用
收藏
页数:1
相关论文
共 50 条
[41]   PREDICTORS OF PROSTATE CANCER SPECIFIC MORTALITY IN ELDERLY MEN WITH INTERMEDIATE-RISK PROSTATE CANCER TREATED WITH BRACHYTHERAPY WITH OR WITHOUT EXTERNAL BEAM RADIATION THERAPY [J].
Nanda, Akash ;
Chen, Ming-Hui ;
Moran, Brian J. ;
Braccioforte, Michelle H. ;
Dosoretz, Daniel ;
Salenius, Sharon ;
Katin, Michael ;
Ross, Rudi ;
D'Amico, Anthony V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01) :147-152
[42]   Personalizing the Management of Men with Intermediate-risk Prostate Cancer [J].
D'Amico, Anthony V. .
EUROPEAN UROLOGY, 2013, 64 (06) :903-904
[43]   Intermediate-risk profile in prostate cancer. Role of combined radiation and hormone therapy [J].
Beck, Marcus ;
Boehmer, Dirk ;
Hoecht, Stefan ;
Zschaeck, Sebastian ;
Budach, Volker ;
Wiegel, Thomas ;
Ghadjar, Pirus .
ONKOLOGE, 2019, 25 (04) :322-329
[44]   Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy [J].
Cagney, Daniel N. ;
Dunne, Mary ;
O'Shea, Carmel ;
Finn, Marie ;
Noone, Emma ;
Sheehan, Martina ;
McDonagh, Lesley ;
O'Sullivan, Lydia ;
Thirion, Pierre ;
Armstrong, John .
BMC UROLOGY, 2017, 17
[45]   Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy [J].
Daniel N. Cagney ;
Mary Dunne ;
Carmel O’Shea ;
Marie Finn ;
Emma Noone ;
Martina Sheehan ;
Lesley McDonagh ;
Lydia O’Sullivan ;
Pierre Thirion ;
John Armstrong .
BMC Urology, 17
[46]   Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy [J].
Karlsdottir, Asa ;
Muren, Ludvig Paul ;
Wentzel-Larsen, Tore ;
Johannessen, Dag C. ;
Haukaas, Svein Andreas ;
Halvorsen, Ole Johan ;
Dahl, Olav .
ACTA ONCOLOGICA, 2009, 48 (06) :874-881
[47]   Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer Statement from the DEGRO working group on prostate cancer [J].
Beck, Marcus ;
Boehmer, Dirk ;
Aebersold, Daniel M. ;
Albrecht, Clemens ;
Flentje, Michael ;
Ganswindt, Ute ;
Hoecht, Stefan ;
Hoelscher, Tobias ;
Mueller, Arndt-Christian ;
Niehoff, Peter ;
Pinkawa, Michael ;
Sedlmayer, Felix ;
Zips, Daniel ;
Zschaeck, Sebastian ;
Budach, Volker ;
Wiegel, Thomas ;
Ghadjar, Pirus .
STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (02) :109-116
[48]   TESTOSTERONE THERAPY AFTER RADIATION THERAPY FOR LOW, INTERMEDIATE, AND HIGH RISK PROSTATE CANCER [J].
Pastuszak, A. W. ;
Khanna, A. ;
Badhiwala, N. ;
Morgentaler, A. ;
Hulth, M. ;
Conners, W. P. ;
Sarosdy, M. ;
Carrion, R. ;
Lipshultz, L., I ;
Khera, M. .
JOURNAL OF SEXUAL MEDICINE, 2015, 12 :119-119
[49]   Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer [J].
Pastuszak, Alexander W. ;
Khanna, Abhinav ;
Badhiwala, Niraj ;
Morgentaler, Abraham ;
Hult, Mariam ;
Conners, William P. ;
Sarosdy, Michael F. ;
Yang, Christopher ;
Carrion, Rafael ;
Lipshultzk, Larry I. ;
Khera, Mohit .
JOURNAL OF UROLOGY, 2015, 194 (05) :1271-1276
[50]   Radiation treatment for patients with intermediate-risk prostate cancer [J].
Greene, David E. ;
Mayadev, Jyoti S. ;
Valicenti, Richard K. .
THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (03) :113-124